跳至主要内容
临床试验/EUCTR2006-001491-21-DE
EUCTR2006-001491-21-DE进行中(未招募)不适用

Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning - Escitaloprame, sleep, blood-brain-barrier

Max Planck Institute of Psychiatry0 个研究点目标入组 58 人开始时间: 2006年6月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • healthy male volunteers, 20 to 30, or 50 to 60 years old,
  • genotype A/A or B/B of the ABCB1 gene,
  • capable to perform all tests and examinations,
  • capable to understand the aims of the study,
  • written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • participation in another trial during the last month,
  • psychiatric disorders, present or during life time,
  • sleep disorders present or during the last 3 months,
  • night work or transmeridian flight during the last 3 months,
  • serious somatic disorders,
  • intake of drugs during more than 2 days during the last 3 months,
  • any drug intake during the last month,
  • abuse of alcohol,
  • more than 2 cups coffee per day,
  • recreational drugs during the last 4 months.

研究者

发起方
Max Planck Institute of Psychiatry

相似试验